Advances in cancer therapeutics have improved patient survival rates. However, cancer
survivors may suffer from adverse events either at the time of therapy or later in life …

Cardiac ageing is an intricate and multifaceted process with considerable impact on public
health, especially given the global demographic shift towards aged populations. This review …

Background and purpose MicroRNA (miRNA) therapy is a promising approach to induce
cardioprotection. We have previously identified cardiac microRNA‐125b*(microRNA‐125b …

Activins and inhibins, members of the transforming growth factor β (TGFβ) superfamily, were
initially recognized for their opposing effects on the secretion of follicle-stimulating hormone …

Background Pulmonary arterial hypertension (PAH) ultimately leads to right ventricular
failure and premature death. The identification of circulating biomarkers with prognostic …

Background Cardiovascular dysfunction and hypertension can persist postpartum following
hypertensive disorders of pregnancy (HDPs). This study hypothesized that activin A …

Recent advances in genomics and proteomics have helped in understanding the molecular
mechanisms and pathways of comorbidities and heart failure. In this narrative review, we …

Cardiac fibroblasts (CF) are key players after myocardial infarction (MI), but their signaling is
only incompletely understood. Here we report a first secretome atlas of CF in control (cCF) …

Myocardial infarction (MI) is still the leading cause of death worldwide. Especially cardiac
fibrosis, which mediates myocardial stiffness and impairs cardiac function resulting in heart …